COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY

The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-I antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of...

Full description

Saved in:
Bibliographic Details
Main Authors GADEK, THOMAS, SEMBA, CHARLES, BURNIER, JOHN
Format Patent
LanguageEnglish
French
Published 30.04.2009
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-I antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of a LFA-I antagonist, after the patient is diagnosed with diabetic retinopathy.
Bibliography:Application Number: CA20082702984